BALAXI PHARMACEUTICALS
Back to Cashflow Statement
|
BALAXI PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹34 Cr | ₹30 Cr | ₹26 Cr | ₹-0.16 Cr | ₹3.65 Cr |
What is the latest Cash Flow from Financing Activities ratio of BALAXI PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹34 Cr |
| Mar2024 | ₹30 Cr |
| Mar2023 | ₹26 Cr |
| Mar2022 | ₹-0.16 Cr |
| Mar2021 | ₹3.65 Cr |
How is Cash Flow from Financing Activities of BALAXI PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹34 Cr | 11.97 | |
| Mar2024 | ₹30 Cr | 18.58 | |
| Mar2023 | ₹26 Cr | Positive | |
| Mar2022 | ₹-0.16 Cr | Negative | |
| Mar2021 | ₹3.65 Cr | - | |
Compare Cash Flow from Financing Activities of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹141.1 Cr | 11.4% | 27.7% | -62.5% | Stock Analytics | |
| ADANI ENTERPRISES | ₹287,023.0 Cr | 8.1% | 10.1% | -3.2% | Stock Analytics | |
| REDINGTON | ₹17,824.5 Cr | 4.4% | -7.2% | 11.9% | Stock Analytics | |
| HONASA CONSUMER | ₹11,222.0 Cr | 3.8% | 23.1% | 52.2% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹9,803.5 Cr | 5% | 31.8% | 38% | Stock Analytics | |
| MMTC | ₹9,285.0 Cr | 5.4% | 11.2% | 21.3% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | 11.4% |
27.7% |
-62.5% |
| SENSEX | 0.6% |
1.5% |
6.6% |
You may also like the below Video Courses